Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

Question 2

How does brivanib compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will I need to undergo while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific lifestyle changes I should consider while on this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer clinical trial (NCT00355238). Contact the study team or your healthcare provider for specific answers.

What this study is about